Ab biosciences inc has a total of 17 patent applications. It decreased the IP activity by 72.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are TUSK THERAPEUTICS LTD, SYSTIMMUNE INC and JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Chile | 1 | |
#7 | China | 1 | |
#8 | Colombia | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 | |
#13 | Taiwan | 1 | |
#14 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Chang Hsiu-Ching | 12 |
#2 | Lee Jeng-Shin | 11 |
#3 | Hsu Yen-Ming | 10 |
#4 | Chang Hsiu Ching | 2 |
#5 | Lee Jeng Shin | 2 |
#6 | Hsu Yen Ming | 2 |
#7 | Yen-Ming Hsu | 1 |
#8 | Yen- Ming Hsu | 1 |
#9 | Jeng- Shin Lee | 1 |
#10 | Hsiu-Ching Chang | 1 |
Publication | Filing date | Title |
---|---|---|
SG11201808541VA | Recombinant intravenous immunoglobulin (rivig) compositions and methods for their production and use | |
US2015099862A1 | Human control antibodies and uses therefor | |
EP2528948A2 | Novel lowered affinity antibodies and methods of making the same |